MEDICAL RESEARCH INSTITUTES ASSOCIATION RESPONDS TO DRAFT NATIONAL RESEARCH STRATEGY National workforce plan welcomed, though concern remains on the indirect costs of research
With
Dr Saraid Billiards,
Chief Executive Officer
Association of Australian Medical Research Institutes (AAMRI)
SEGMENT
Filmed in Melbourne | October 2025
On 27 August 2025, the Minister for Health, Disability and Ageing announced the release of the draft National Health and Medical Research Strategy (the National Strategy).
The aims of the National Strategy are to build on Australia’s strengths in health and medical research and leverage Australia’s world leading research capability.
The developed strategy aims to attract researchers and investors, strengthen coordination and impact and improve health outcomes in communities.
Involved in the initial consultation phase, was the Association of Australian Medical Research Institutes (AAMRI), the peak body for medical research institutes across Australia. Member institutes work on a broad spectrum of human health issues such as preventive health, chronic disease, mental health, immunology and Indigenous health. Their research ranges from fundamental biomedical discovery through to clinical research and the translation of research findings.
AAMRI CEO Dr Saraid Billiards has been working Health, Ageing and Disability Minister, The Hon Mark Butler MP, his office and subsequently with Ms Rosemary Huxtable AO, who in November 2024 was appointed to develop the National Health and Medical Research Strategy.
Australian Health Journal spoke with Dr Billiards about the advocacy work of AAMRI, the reviews, reports, announcements and Phase 1 consultation period leading to the draft release. Consultation on the draft Strategy is open until 8 October 2025.
Source: Adapted from AAMRI release, NHMRC news story and Department of Health, Disability & Aged Care website.
-
World-first clinical trial improves patient outcomes for kidney transplants
A world-first clinical trial conducted at the Royal Adelaide Hospital (RAH) and at hospitals across Australia and New Zealand has identified the best fluid treatment to reduce the risk of patients requiring dialysis after a kidney transplant.
Australian Health Journal spoke with the lead-author of the study, RAH Nephrologist and University of Adelaide researcher, Dr Michael Collins.
-
Taiwanese health and research delegation visit Paratus clinical trial site in Canberra
In late August 2025, a Taiwanese delegation comprising government officials from the Taiwanese FDA, various governmental groups, and physicians and researchers from across Taiwan, visited Paratus Clinical’s trial site in Canberra. Their objective was to explore both the differences and similarities between the clinical research ecosystems of Taiwan and Australia.
-
Bridging the orthodontic knowledge gap
In recent years, the orthodontic sector has been growing rapidly due to success in B2C marketing and companies like Invisalign reaching the consumer, but there has also been a lack of knowledge sharing among general dental practitioners and specialists.
General dentists require mentorship and guidance from orthodontists to feel confident in providing orthodontic treatment to their patients, ultimately improving the quality of care in the community.
